The interplay between copper(II), human serum albumin, fatty acids, and carbonylating agent interferes with Cys 34 thiol reactivity and copper binding.


Journal

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry
ISSN: 1432-1327
Titre abrégé: J Biol Inorg Chem
Pays: Germany
ID NLM: 9616326

Informations de publication

Date de publication:
02 2019
Historique:
received: 09 08 2018
accepted: 13 11 2018
pubmed: 21 11 2018
medline: 26 11 2019
entrez: 21 11 2018
Statut: ppublish

Résumé

Cys34 thiol group of human serum albumin (HSA) represents major plasma antioxidant. Its reactivity is influenced by multiple factors. The influence of fatty acids (FA; saturated, mono, and poly unsaturated acids from fish oil) binding to HSA, on copper(II) binding affinity and Cys34 thiol group accessibility/reactivity, in the presence of carbonylation agent (methylglyoxal, MG) was examined. HSA-copper(II) content, thiol group reactivity, and HSA carbonylation level were monitored spectrophotometrically. Changes in HSA were followed by fluorescence spectroscopy and native PAG electrophoresis. FA/HSA molar ratio was screened by GC. Together, binding of copper(II) ions and FA to HSA increase the reactivity of Cys34 thiol group (depending on the type of FA), with constant contribution of copper(II) ions of one-third. Carbonylation of FA-HSA-Cu(II) complexes caused a decrease in the Cys34 thiol group content, accompanied by a decrease in the content of HSA-bound copper. The carbonylation level of guanidine groups was not affected by FAs and copper(II) binding. Fluorescent emission spectra of FA-HSA-Cu(II)-MG complexes showed conformational changes in HSA molecule. Although binding of fatty acids and copper ions caused a significant increase in the thiol group reactivity, Cys34 thiol from FA-HSA-Cu(II) complexes reacted with MG in smaller extent than expected, probably as a consequence of conformational changes introduced by carbonylation. Increase in the percentage of reacted-free thiol groups with MG (due to FA and copper binding) may not seem to be very significant, but it is very important in complex biological systems, where catalytic metal is present.

Identifiants

pubmed: 30456476
doi: 10.1007/s00775-018-1628-7
pii: 10.1007/s00775-018-1628-7
doi:

Substances chimiques

Fatty Acids 0
Pyruvaldehyde 722KLD7415
Copper 789U1901C5
Cysteine K848JZ4886
Serum Albumin, Human ZIF514RVZR

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

61-70

Références

Biochem J. 1997 Jun 1;324 ( Pt 2):565-70
pubmed: 9182719
J Biol Chem. 1996 Apr 26;271(17):9982-6
pubmed: 8626637
Anal Biochem. 2013 Feb 15;433(2):162-7
pubmed: 23103397
Chem Biol Interact. 2014 Dec 5;224:42-50
pubmed: 25451573
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
FEBS J. 2007 Aug;274(15):3855-63
pubmed: 17617229
Sci Pharm. 2013 Dec 28;82(2):233-45
pubmed: 24959397
Am J Clin Nutr. 1998 May;67(5 Suppl):952S-959S
pubmed: 9587135
Clin Chim Acta. 2013 Oct 21;425:64-76
pubmed: 23891854
J Pharm Sci. 2017 Sep;106(9):2195-2203
pubmed: 28302542
Nat Struct Biol. 1998 Sep;5(9):827-35
pubmed: 9731778
Arch Biochem Biophys. 2003 May 1;413(1):53-66
pubmed: 12706341
Biochim Biophys Acta. 1999 Nov 23;1441(2-3):131-40
pubmed: 10570241
Clin Sci (Lond). 2016 Oct 1;130(19):1677-96
pubmed: 27555612
J Mol Biol. 2000 Nov 10;303(5):721-32
pubmed: 11061971
Diabetes Care. 1991 Nov;14(11):1050-6
pubmed: 1797486
J Mol Biol. 2001 Dec 14;314(5):955-60
pubmed: 11743713
Diabetes. 2015 Mar;64(3):960-72
pubmed: 25157094
Aliment Pharmacol Ther. 2002 Dec;16 Suppl 5:6-11
pubmed: 12423448
Metallomics. 2015 Oct;7(10):1431-8
pubmed: 26325422
Mol Cell Ther. 2016 Feb 27;4:3
pubmed: 26925240
Biochim Biophys Acta. 2013 Dec;1830(12):5444-55
pubmed: 23811338
J Clin Invest. 1991 Apr;87(4):1431-41
pubmed: 2010553
Clin Chim Acta. 2011 Nov 20;412(23-24):2105-16
pubmed: 21835170
Biochimie. 2011 Apr;93(4):645-58
pubmed: 21167901
Int J Pept Protein Res. 1984 Aug;24(2):96-103
pubmed: 6480219
Mol Aspects Med. 2005 Aug-Oct;26(4-5):268-98
pubmed: 16112185
Am J Epidemiol. 2000 Jun 15;151(12):1182-8
pubmed: 10905530
J Biol Inorg Chem. 2007 Aug;12(6):913-8
pubmed: 17516096
J Pharm Sci. 2010 Mar;99(3):1614-25
pubmed: 19760671
Biol Trace Elem Res. 2008 Apr;122(1):1-18
pubmed: 18193174
J Protein Chem. 1995 Jul;14(5):359-72
pubmed: 8590604
Clin Sci (Lond). 2015 Jun;128(12):839-61
pubmed: 25818485
Glycoconj J. 2016 Aug;33(4):513-25
pubmed: 27406712
Ann N Y Acad Sci. 2005 Jun;1043:111-7
pubmed: 16037229
Clin Chem Lab Med. 2003 Sep;41(9):1166-73
pubmed: 14598866
FEBS Lett. 2008 Jun 11;582(13):1783-7
pubmed: 18474236
FEBS Lett. 1995 Nov 27;376(1-2):1-5
pubmed: 8521951
Br J Nutr. 2002 May;87(5):393-403
pubmed: 12010579
Am J Physiol Endocrinol Metab. 2016 Apr 1;310(7):E550-64
pubmed: 26814014
J Biol Chem. 1967 Jan 25;242(2):173-81
pubmed: 6016603

Auteurs

Ana Z Penezić (AZ)

Institute for the Application of Nuclear Energy, INEP, Banatska 31b, 11000, Belgrade, Serbia. anap@inep.co.rs.

Jelena M Aćimović (JM)

Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000, Belgrade, Serbia.

Ivan D Pavićević (ID)

Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000, Belgrade, Serbia.

Vesna B Jovanović (VB)

Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000, Belgrade, Serbia.

Marija Takić (M)

Laboratory for Nutrition and Metabolism, Institute for Medical Research, University of Belgrade, Belgrade, Serbia.

Ljuba M Mandić (LM)

Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000, Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH